These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. New insights into the role of macrophages in adipose tissue inflammation and Fatty liver disease: modulation by endogenous omega-3 Fatty Acid-derived lipid mediators. Clària J; González-Périz A; López-Vicario C; Rius B; Titos E Front Immunol; 2011; 2():49. PubMed ID: 22566839 [TBL] [Abstract][Full Text] [Related]
5. Pro-resolving mediators produced from EPA and DHA: Overview of the pathways involved and their mechanisms in metabolic syndrome and related liver diseases. López-Vicario C; Rius B; Alcaraz-Quiles J; García-Alonso V; Lopategi A; Titos E; Clària J Eur J Pharmacol; 2016 Aug; 785():133-143. PubMed ID: 25987424 [TBL] [Abstract][Full Text] [Related]
6. Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. González-Périz A; Horrillo R; Ferré N; Gronert K; Dong B; Morán-Salvador E; Titos E; Martínez-Clemente M; López-Parra M; Arroyo V; Clària J FASEB J; 2009 Jun; 23(6):1946-57. PubMed ID: 19211925 [TBL] [Abstract][Full Text] [Related]
7. Immuno-Resolving Ability of Resolvins, Protectins, and Maresins Derived from Omega-3 Fatty Acids in Metabolic Syndrome. Kwon Y Mol Nutr Food Res; 2020 Feb; 64(4):e1900824. PubMed ID: 31797565 [TBL] [Abstract][Full Text] [Related]
13. Cell type-specific modulation of lipid mediator's formation in murine adipose tissue by omega-3 fatty acids. Kuda O; Rombaldova M; Janovska P; Flachs P; Kopecky J Biochem Biophys Res Commun; 2016 Jan; 469(3):731-6. PubMed ID: 26707880 [TBL] [Abstract][Full Text] [Related]
14. Omega-3 fatty acids and inflammatory processes: from molecules to man. Calder PC Biochem Soc Trans; 2017 Oct; 45(5):1105-1115. PubMed ID: 28900017 [TBL] [Abstract][Full Text] [Related]
15. Modulation of inflammatory cytokines by omega-3 fatty acids. Kang JX; Weylandt KH Subcell Biochem; 2008; 49():133-43. PubMed ID: 18751910 [TBL] [Abstract][Full Text] [Related]
16. Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation. Weylandt KH; Chiu CY; Gomolka B; Waechter SF; Wiedenmann B Prostaglandins Other Lipid Mediat; 2012 Mar; 97(3-4):73-82. PubMed ID: 22326554 [TBL] [Abstract][Full Text] [Related]
17. Resolvins: anti-inflammatory and proresolving mediators derived from omega-3 polyunsaturated fatty acids. Zhang MJ; Spite M Annu Rev Nutr; 2012 Aug; 32():203-27. PubMed ID: 22404117 [TBL] [Abstract][Full Text] [Related]
18. Implications for eicosapentaenoic acid- and docosahexaenoic acid-derived resolvins as therapeutics for arthritis. Souza PR; Norling LV Eur J Pharmacol; 2016 Aug; 785():165-173. PubMed ID: 26165764 [TBL] [Abstract][Full Text] [Related]
19. Lipoxins and new lipid mediators in the resolution of inflammation. Schwab JM; Serhan CN Curr Opin Pharmacol; 2006 Aug; 6(4):414-20. PubMed ID: 16750421 [TBL] [Abstract][Full Text] [Related]
20. Resolvins and protectins: mediating solutions to inflammation. Kohli P; Levy BD Br J Pharmacol; 2009 Oct; 158(4):960-71. PubMed ID: 19594757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]